BIOVERATIV

Plaintiff, the Settling Defendants, Bioverativ, and Sanofi have engaged in substantial settlement negotiations, which included a June 10, 2022 mediation before former U.S. District Judge Layn R. Phillips following the exchange of opening and reply briefs. The first full-day mediation did not result in a settlement, but the parties periodically continued settlement discussions through Judge Phillips over the next nine months as the litigation progressed. Following additional written submissions to Judge Phillips informed by the evidence adduced during oral and written discovery, a second formal mediation session was held on March 12, 2023. At the end of this mediation session, Plaintiff, the Settling Defendants, Bioverativ, and Sanofi reached an agreement to settle the Released Plaintiff's Claims for $84,000,000 in cash, subject to Court approval, the terms of which are reflected in the Stipulation... Following briefing and negotiations between Plaintiff's Counsel and Bioverativ's..

Also known as: Bioverativ Stockholder Settlement, Bioverativ, Inc.

Primary location: Los Angeles United States